Advertisement
Screener

Fibrocell Science, Inc. Forms 3, 4 and 5: Warrants

Fibrocell Science, Inc. Forms 3, 4 and 5: Warrants

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows, 17 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2017-12-11: Reporting owner INTREXON CORP | KIRK RANDAL J; Form 4; Security Warrant to Purchase Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2017-12-11: Reporting owner INTREXON CORP | KIRK RANDAL J; Form 4; Security Warrant to Purchase Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2017-12-11: Reporting owner INTREXON CORP | KIRK RANDAL J; Form 4; Security Warrant to Purchase Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
  • 2017-03-08: Reporting owner KIRK RANDAL J | INTREXON CORP; Form 4; Security Warrant to Purchase Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2017-12-11INTREXON CORP | KIRK RANDAL J
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by NRM VII Holdings
P Open market or private purchase of non-derivative or derivative security+2,567,121
2,567,121 owned after
$0.77
exercise price
2017-12-13
2017-12-11INTREXON CORP | KIRK RANDAL J
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Kapital Joe
P Open market or private purchase of non-derivative or derivative security+155,347
155,347 owned after
$0.77
exercise price
2017-12-13
2017-12-11INTREXON CORP | KIRK RANDAL J
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Mascara Kaboom
P Open market or private purchase of non-derivative or derivative security+4,805
4,805 owned after
$0.77
exercise price
2017-12-13
2017-03-08KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Kapital Joe
P Open market or private purchase of non-derivative or derivative security+136,634
136,634 owned after
$0.85
exercise price
2017-03-10
2017-03-08KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Mascara Kaboom
P Open market or private purchase of non-derivative or derivative security+3,867
3,867 owned after
$0.85
exercise price
2017-03-10
2017-03-08KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by NRM VII
P Open market or private purchase of non-derivative or derivative security+2,250,594
2,250,594 owned after
$0.85
exercise price
2017-03-10
2017-03-08KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Intrexon
P Open market or private purchase of non-derivative or derivative security+1,496,529
1,496,529 owned after
$0.85
exercise price
2017-03-10
2016-09-07KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Kapital Joe
P Open market or private purchase of non-derivative or derivative security$1.50
exercise price
2016-09-09
2016-09-07KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Mascara Kaboom
P Open market or private purchase of non-derivative or derivative security$1.50
exercise price
2016-09-09
2016-09-07KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by NRM VII Holdings
P Open market or private purchase of non-derivative or derivative security$1.50
exercise price
2016-09-09
2016-09-07KIRK RANDAL J | INTREXON CORP
10% Owner | 10% Owner
4Warrant to Purchase Common Stock
Derivative · Indirect · by Intrexon
P Open market or private purchase of non-derivative or derivative security$1.50
exercise price
2016-09-09
2014-05-23
holding as of filing
Maslowski John Michael
Officer (V.P., Scientific Affairs)
3Warrant to Purchase Common Stock
Derivative · Direct
Holding$6.25
exercise price
2014-05-23
2012-05-24Korkos George J
Director
4Warrant to Purchase Common Stock
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+100,000
700,000 owned after
$0.30
exercise price
2012-05-30
2012-05-14Mazur Marc
Director
4Warrant to Purchase Common Stock
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+100,000
600,000 owned after
$0.30
exercise price
2012-05-16
2011-01-21Korkos George J
Director
4Warrant (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
500,000 owned after
$0.50
exercise price
2011-01-25
2010-03-04
holding as of filing
Deerfield Special Situations Fund, L.P. | DEERFIELD CAPITAL LP | Flynn James E
| |
3Common Stock Warrants (right to buy)
Derivative · Indirect · Through Deerfield Special Situations Fund, L.P.
Holding$0.98
exercise price
2010-03-04
2010-03-04
holding as of filing
Deerfield Special Situations Fund, L.P. | DEERFIELD CAPITAL LP | Flynn James E
| |
3Common Stock Warrants (right to buy)
Derivative · Indirect · Through Deerfield Special Situations Fund International Limited
Holding$0.98
exercise price
2010-03-04